Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
Authors:
- Paulus KirchhofPaulus Kirchhof
- Günter BreithardtGBGünter Breithardt
- A. John CammACA. John Camm
- Harry J. CrijnsHCHarry J. Crijns
- Karl-Heinz KuckKKKarl-Heinz Kuck
- Panos VardasPVPanos Vardas
- Karl WegscheiderKWKarl Wegscheider
Open Access
- 1 September 2013
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 166 (3) , 442-448
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial FibrillationCirculation, 2012
- Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trialThe Lancet, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Lenient versus Strict Rate Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2010
- Can we improve outcomes in AF patients by early therapy?BMC Medicine, 2009
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or FlutterNew England Journal of Medicine, 2007
- Amiodarone versus Sotalol for Atrial FibrillationNew England Journal of Medicine, 2005
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002